Study of GenSci134 for children with growth hormone deficiency
Treatments studied
Part of Hormones & metabolism clinical trials.
This study tests a new once-a-week injection (GenSci134) for children with growth hormone deficiency. It aims to see if it is safe and helps them grow. Your child may be able to join if they have not been treated before and meet the age and height requirements.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child has been diagnosed with growth hormone deficiency (a condition where the body doesn't make enough growth hormone) through two specific tests.
- Your child has not had any prior growth hormone treatment.
- Your child is between 3 and 12 years old, depending on gender and study part.
- Your child's height is well below average for their age and sex — more than 2 standard deviations below the mean.
- Your child has no other conditions that could cause short stature, like Turner syndrome or being born small for gestational age.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an oral medication called GS3-007a for children who have not yet reached puberty and have growth hormone deficiency. The goal is to see if it helps them grow taller.
This trial is testing an experimental growth hormone treatment for children who are short for their age but otherwise healthy. Participation may help determine if the treatment can safely improve growth.
This study tests if growth hormone can safely help children who are shorter than average for their age and gender. It is for children with certain conditions that cause short stature.
This study tests a new growth hormone injection (Jinpei) to help children who were born small for gestational age (SGA) and are still short for their age. The treatment may help them grow taller.
This trial tests a weekly growth hormone injection called PEG-rhGH to see if it helps short children born small for gestational age grow taller. It may be an option if your child has never taken growth hormone before and meets the height and age requirements.
This trial tests a new growth hormone treatment called GenSci134 in healthy adults and adults with growth hormone deficiency (AGHD). The goal is to see if it is safe and effective for people who need growth hormone replacement.
Hear when a new Pediatric Growth Hormone Deficiency trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.